$HMELF
Hold Me Ltd

2022 Q4 Form 20-F Financial Statement

#000117891323001628 Filed on May 01, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021 Q4
Revenue $108.7K
YoY Change 10.4%
Cost Of Revenue $158.9K
YoY Change -65.43%
Gross Profit -$50.22K
YoY Change -86.1%
Gross Profit Margin -46.22%
Selling, General & Admin $603.9K
YoY Change -5.32%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $150.2K
YoY Change -65.28%
% of Gross Profit
Operating Expenses $603.9K
YoY Change -5.32%
Operating Profit -$654.1K
YoY Change -34.53%
Interest Expense $48.53K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$63.41K
YoY Change 13.62%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$711.9K
YoY Change -32.51%
Net Earnings / Revenue -655.09%
Basic Earnings Per Share -$0.31
Diluted Earnings Per Share -$0.31
COMMON SHARES
Basic Shares Outstanding 2.282M shares 2.282M shares
Diluted Shares Outstanding 2.282M shares

Balance Sheet

Concept 2022 Q4 2022 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $451.8K $783.4K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $0.00 $0.00
Receivables
Other Receivables
Total Short-Term Assets $702.7K $835.1K
YoY Change -15.86%
LONG-TERM ASSETS
Property, Plant & Equipment $3.395K $200.7K
YoY Change -98.31%
Goodwill
YoY Change
Intangibles $0.00 $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $3.395K $200.7K
YoY Change -98.31%
TOTAL ASSETS
Total Short-Term Assets $702.7K $835.1K
Total Long-Term Assets $3.395K $200.7K
Total Assets $706.1K $1.036M
YoY Change -31.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due $37.58K $36.55K
YoY Change 2.82%
Total Short-Term Liabilities $2.749M $2.329M
YoY Change 18.0%
LONG-TERM LIABILITIES
Long-Term Debt $16.22K $53.49K
YoY Change -69.68%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $16.22K $53.49K
YoY Change -69.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.749M $2.329M
Total Long-Term Liabilities $16.22K $53.49K
Total Liabilities $2.765M $2.383M
YoY Change 16.04%
SHAREHOLDERS EQUITY
Retained Earnings -$3.231M -$2.520M
YoY Change 28.25%
Common Stock $22.82K $22.82K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.059M -$1.347M
YoY Change
Total Liabilities & Shareholders Equity $706.1K $1.036M
YoY Change -31.84%

Cashflow Statement

Concept 2022 Q4 2022 2021 Q4
OPERATING ACTIVITIES
Net Income -$711.9K
YoY Change -32.51%
Depreciation, Depletion And Amortization $150.2K
YoY Change -65.28%
Cash From Operating Activities -$351.5K
YoY Change 148.7%
INVESTING ACTIVITIES
Capital Expenditures -$47.10K
YoY Change -190.45%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $47.10K
YoY Change -190.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -27.20K
YoY Change -103.29%
NET CHANGE
Cash From Operating Activities -351.5K
Cash From Investing Activities 47.10K
Cash From Financing Activities -27.20K
Net Change In Cash -331.6K
YoY Change -152.34%
FREE CASH FLOW
Cash From Operating Activities -$351.5K
Capital Expenditures -$47.10K
Free Cash Flow -$304.4K
YoY Change 57.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Security12b Title
Security12bTitle
Ordinary Shares, par value NIS 0.01 per share
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001853630
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Type
DocumentType
20-F
CY2022 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2022 dei Entity File Number
EntityFileNumber
333-255462
CY2022 dei Entity Registrant Name
EntityRegistrantName
Hold Me Ltd.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
L3
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
30 Golomb Street
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Ness Ziyona
CY2022 dei Entity Address Country
EntityAddressCountry
IL
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
7401337
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2282124 shares
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2022 dei Auditor Firm
AuditorFirmId
5041
CY2022 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
451784
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
783380
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
3030
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
17173
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
212151
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
35716
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
34565
CY2022Q4 us-gaap Assets Current
AssetsCurrent
702681
CY2021Q4 us-gaap Assets Current
AssetsCurrent
835118
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3395
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
200733
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0
CY2022Q4 us-gaap Assets
Assets
706076
CY2021Q4 us-gaap Assets
Assets
1035851
CY2022Q4 us-gaap Debt Current
DebtCurrent
46618
CY2021Q4 us-gaap Debt Current
DebtCurrent
36547
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2604
CY2021Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
5466
CY2022Q4 hold Payables And Credit Balances
PayablesAndCreditBalances
2699585
CY2021Q4 hold Payables And Credit Balances
PayablesAndCreditBalances
2287409
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2748807
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2329422
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
16218
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
53488
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
100000
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
100000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
990000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
990000000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2282124 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2282124 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2282124 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2282124 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
22821
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
22821
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1049703
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1049703
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3231473
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2519583
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2058949
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1347059
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
706076
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1035851
CY2022 us-gaap Revenues
Revenues
108671
CY2021 us-gaap Revenues
Revenues
98434
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
158895
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
459670
CY2022 us-gaap Gross Profit
GrossProfit
-50224
CY2021 us-gaap Gross Profit
GrossProfit
-361236
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
603867
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
637797
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-654091
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-999033
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-63412
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-55812
CY2022 hold Income Loss After Financing Expense
IncomeLossAfterFinancingExpense
-717503
CY2021 hold Income Loss After Financing Expense
IncomeLossAfterFinancingExpense
-1054845
CY2022 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
5613
CY2021 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
0
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-711890
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1054845
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.7
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.7
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2282124 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2282124 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1499410 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1499410 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1164735
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
872521
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1054845
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1347059
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1347059
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-711890
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2058949
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
105421
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-711890
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1054845
CY2022 us-gaap Depreciation
Depreciation
150235
CY2021 us-gaap Depreciation
Depreciation
432731
CY2022 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
212151
CY2021 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-1832
CY2022 hold Decrease Increase In Other Accounts Receivable And Prepaid Expenses
DecreaseIncreaseInOtherAccountsReceivableAndPrepaidExpenses
-12992
CY2021 hold Decrease Increase In Other Accounts Receivable And Prepaid Expenses
DecreaseIncreaseInOtherAccountsReceivableAndPrepaidExpenses
-288728
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-2862
CY2021 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
5043
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
412176
CY2021 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
185174
CY2022 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
360390
CY2021 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
913508
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-351500
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-141337
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-47103
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
52075
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
47103
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-52075
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
872521
CY2022 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
10071
CY2021 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-8955
CY2022 hold Repayment Of Long Term Debt And Liabilities
RepaymentOfLongTermDebtAndLiabilities
37270
CY2021 hold Repayment Of Long Term Debt And Liabilities
RepaymentOfLongTermDebtAndLiabilities
36565
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-27199
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
827001
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-331596
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
633589
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
783380
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
149791
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
451784
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
783380
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2519583
CY2022 us-gaap Basis Of Accounting
BasisOfAccounting
<div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:27pt;vertical-align:top;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A.</span></span></td> <td style="width:auto;vertical-align:top;text-align:justify;font-family:'Times New Roman',Times,serif"> <div style="color:rgb(0, 0, 0);font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Financial Statements Reporting Basis</span></span></span></div> </td> </tr> </table> <div style="line-height:1.25"> </div> <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The financial statements are drawn up on the basis of generally accepted accounting principles ("GAAP"), and are expressed in New Israeli Shekel ("NIS") based on historical values, and provide no information on changes in the general purchasing power of the Israeli currency on the business results.</span></span></div> <div style="line-height:1.25"> </div> <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Those reports are filed as part of form F-1 (Registration Statement Under the Securities Act of 1933). Since the Company was incorporated in Israel and is considered a Foreign Issuer and as such is allowed to file the statement and the financial reports in its home country currency, New Israeli Shekel (NIS).</span></span></div> </div>
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div> <div> <div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:27pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">D.</span></span></td> <td style="width:auto;vertical-align:top;text-align:justify"> <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Use of Estimates in Preparing the Financial Statements</span></span></span></div> </td> </tr> </table> <div> </div> <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.</span></span></div> <div style="line-height:1.25"> </div> <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following are the hierarchical levels of inputs to measure fair value:</span></span></div> <div style="text-align:justify;line-height:1.25"> </div> <table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:8%;vertical-align:top"> <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">- Level 1:</span></span></div> </td> <td style="width:92%;vertical-align:top"> <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Quoted prices in active markets for identical instruments;</span></span></div> </td> </tr> <tr> <td style="width:8%;vertical-align:top"> <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">- Level 2:</span></span></div> </td> <td style="width:92%;vertical-align:top"> <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other significant observable inputs (including quoted prices in active markets for similar instruments);</span></span></div> </td> </tr> <tr> <td style="width:8%;vertical-align:top"> <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">- Level 3:</span></span></div> </td> <td style="width:92%;vertical-align:top"> <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Significant unobservable inputs (including assumptions in determining the fair value of certain investments).</span></span></div> </td> </tr> </table> <div style="text-align:justify;line-height:1.25"> </div> <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The carrying values for cash and cash equivalents, accounts receivable, other current assets, accounts payable and accrued liabilities, and deferred revenue approximate their fair value due to their short maturities.</span></span></div> <div style="text-align:justify;line-height:1.25"> </div> </div> </div> </div>
CY2022Q4 hold Pro Rated Licensing Fee
ProRatedLicensingFee
212151
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
451784
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
783380
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0
CY2022Q4 hold Receivable From Institutions
ReceivableFromInstitutions
35716
CY2021Q4 hold Receivable From Institutions
ReceivableFromInstitutions
13870
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
20695
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
0
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
0
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
35716
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
34565
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1779161
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
88322
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1317230
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1313835
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3395
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
200733
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
37579
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
36547
CY2022Q4 us-gaap Debt Current
DebtCurrent
46618
CY2021Q4 us-gaap Debt Current
DebtCurrent
36547
CY2022Q4 hold Payable Expenses Current
PayableExpensesCurrent
0
CY2021Q4 hold Payable Expenses Current
PayableExpensesCurrent
280000
CY2022Q4 hold Down Payments From Clients
DownPaymentsFromClients
0
CY2021Q4 hold Down Payments From Clients
DownPaymentsFromClients
1453
CY2022Q4 hold Prepaid Revenue
PrepaidRevenue
139500
CY2021Q4 hold Prepaid Revenue
PrepaidRevenue
93000
CY2022Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
780924
CY2021Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
1824634
CY2022Q4 hold Payables And Credit Balances
PayablesAndCreditBalances
2699585
CY2021Q4 hold Payables And Credit Balances
PayablesAndCreditBalances
2287409
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
37579
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
36547
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
16218
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
53488
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
990000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
990000000 shares
CY2021Q4 hold Ordinary Shares Issued And Paid Up Number Of Shares
OrdinarySharesIssuedAndPaidUpNumberOfShares
2282124 shares
CY2022Q4 hold Ordinary Shares Issued And Paid Up Number Of Shares
OrdinarySharesIssuedAndPaidUpNumberOfShares
2282124 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021 hold Preferred Shares Issued And Paid Up Number Of Shares
PreferredSharesIssuedAndPaidUpNumberOfShares
10000000 shares
CY2022 hold Preferred Shares Issued And Paid Up Number Of Shares
PreferredSharesIssuedAndPaidUpNumberOfShares
10000000 shares
CY2021 hold Proceed From Investors Through Registration Statement Filed With Sec
ProceedFromInvestorsThroughRegistrationStatementFiledWithSec
857945
CY2021 hold Proceed From Investors Through Registration Statement Filed With Sec
ProceedFromInvestorsThroughRegistrationStatementFiledWithSec
268018 usd
CY2022Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
100 shares
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
0
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
0
CY2022 us-gaap Advertising Expense
AdvertisingExpense
0
CY2021 us-gaap Advertising Expense
AdvertisingExpense
11794
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
0
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
0
CY2022 us-gaap Management Fee Expense
ManagementFeeExpense
420000
CY2021 us-gaap Management Fee Expense
ManagementFeeExpense
420001
CY2022 us-gaap Communication
Communication
1746
CY2021 us-gaap Communication
Communication
1705
CY2022 us-gaap Professional Fees
ProfessionalFees
176615
CY2021 us-gaap Professional Fees
ProfessionalFees
194147
CY2022 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
0
CY2021 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
0
CY2022 hold Maintenance And Electricity Expense
MaintenanceAndElectricityExpense
808
CY2021 hold Maintenance And Electricity Expense
MaintenanceAndElectricityExpense
1997
CY2022 hold Office Expenses
OfficeExpenses
0
CY2021 hold Office Expenses
OfficeExpenses
0
CY2022 hold Refreshments Expenses
RefreshmentsExpenses
0
CY2021 hold Refreshments Expenses
RefreshmentsExpenses
0
CY2022 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
2715
CY2021 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
0
CY2022 hold Travel And Parking Expense
TravelAndParkingExpense
342
CY2021 hold Travel And Parking Expense
TravelAndParkingExpense
1141
CY2022 us-gaap Depreciation Nonproduction
DepreciationNonproduction
1641
CY2021 us-gaap Depreciation Nonproduction
DepreciationNonproduction
7012
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
603867
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
637797
CY2022Q4 hold Pre Tax Profit Loss As Reported
PreTaxProfitLossAsReported
3231473
CY2021Q4 hold Pre Tax Profit Loss As Reported
PreTaxProfitLossAsReported
2519583
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.23
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.23
CY2022Q4 hold Expected Tax Expense Benefit
ExpectedTaxExpenseBenefit
743239
CY2021Q4 hold Expected Tax Expense Benefit
ExpectedTaxExpenseBenefit
579504
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
743239
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
579504
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
743239
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
579504
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2022Q4 hold Pre Tax Profit Loss As Reported
PreTaxProfitLossAsReported
3231473

Files In Submission

Name View Source Status
0001178913-23-001628-index-headers.html Edgar Link pending
0001178913-23-001628-index.html Edgar Link pending
0001178913-23-001628.txt Edgar Link pending
0001178913-23-001628-xbrl.zip Edgar Link pending
exhibit_12-1.htm Edgar Link pending
exhibit_13-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hold-20221231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
hold-20221231_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
hold-20221231_def.xml Edgar Link unprocessable
hold-20221231_pre.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zk2329585.htm Edgar Link pending
hold-20221231_cal.xml Edgar Link unprocessable
zk2329585_htm.xml Edgar Link completed